Bremelanotide Rescues Men Who Fail Viagra: A Brain Approach When Blood Flow Drugs Don't Work

Bremelanotide (PT-141) significantly improved erectile function in men who had failed sildenafil treatment, in a double-blind placebo-controlled RCT — demonstrating the brain-acting melanocortin approach works where peripheral drugs fail.

Safarinejad, Mohammad Reza et al.·The Journal of urology·2008·Strong EvidenceRCT
RPEP-01413RCTStrong Evidence2008RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
RCT
Evidence
Strong Evidence
Sample
Not reported

What This Study Found

SC bremelanotide significantly improved erectile responses in sildenafil-failure ED patients in a double-blind, placebo-controlled RCT — demonstrating melanocortin central mechanism (desire/arousal) rescues patients where PDE5 peripheral mechanism (blood flow) fails.

Key Numbers

How They Did This

RCT study.

Why This Research Matters

Relevant for pt-141, sexual-health.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding SC bremelanotide significantly improved erectile responses in sildenafil-failure ED patients in a double-blind, placebo-controlled RCT — demonstrating
Evidence Grade:
strong evidence.
Study Age:
Published in 2008.
Original Title:
Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study.
Published In:
The Journal of urology, 179(3), 1066-71 (2008)
Database ID:
RPEP-01413

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

Bremelanotide Rescues Men Who Fail Viagra: A Brain Approach When Blood Flow Drugs Don't Work

What was found?

Bremelanotide (PT-141) significantly improved erectile function in men who had failed sildenafil treatment, in a double-blind placebo-controlled RCT — demonstrating the brain-acting melanocortin approach works where peripheral drugs fail.

Read More on RethinkPeptides

Cite This Study

RPEP-01413·https://rethinkpeptides.com/research/RPEP-01413

APA

Safarinejad, Mohammad Reza; Hosseini, Seyyed Yousof. (2008). Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study.. The Journal of urology, 179(3), 1066-71. https://doi.org/10.1016/j.juro.2007.10.063

MLA

Safarinejad, Mohammad Reza, et al. "Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study.." The Journal of urology, 2008. https://doi.org/10.1016/j.juro.2007.10.063

RethinkPeptides

RethinkPeptides Research Database. "Salvage of sildenafil failures with bremelanotide: a randomi..." RPEP-01413. Retrieved from https://rethinkpeptides.com/research/safarinejad-2008-salvage-of-sildenafil-failures

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.